忽视基于性别的免疫代谢重编程,这是基于免疫的精密医学中的风险业务
1Department of Surgery, Laboratory of Tumor Immunology and Immunotherapy, Morehouse School of Medicine, Atlanta, GA 30310, USA.
Frontiers in bioscience (Landmark edition)
|January 25, 2025
概括
性别/性别差异影响免疫反应和疾病易感性. 了解免疫代谢重编程 (IR) 差异对于开发有效的,性别特定的精准医学和疗法至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 精准医学是一门精准的医学.
- 性别/性别免疫差异的免疫力
背景情况:
- 免疫学的进步已经阐明了各种疾病的免疫参与,包括自身免疫性,传染性和神经退行性疾病.
- 越来越多的证据突出了基于性别/性别的显著免疫差异,导致女性自身免疫疾病发病率较高,以及对感染和疫苗的反应不同.
- 免疫检查点抑制剂 (ICI) 和其他基于免疫的疗法表现出性别特异的疗效和不良事件概况.
研究的目的:
- 强调研究免疫代谢和免疫代谢重编程 (IR) 的性别/性别差异的重要性.
- 突出基于性别的IR研究的需要,以提高基于免疫的精准医学的有效性.
主要方法:
- 审查目前专注于性别/性别差异的免疫学研究.
- 分析免疫代谢和免疫代谢重编程 (IR) 在免疫细胞功能中的作用.
- 检查免疫反应和治疗结果的性别/性别差异.
主要成果:
- 女性表现出更高的自身免疫性疾病的发病率,如系统性红斑狼 (SLE) 和类风湿性关节炎 (RA).
- 与男性相比,生殖年龄的女性通常对感染和疫苗有更强大的免疫反应.
- 免疫治疗的治疗效果和不良事件,如ICI,受性别/性别的影响.
结论:
- 性别/性别差异显著影响免疫反应,疾病易感性和治疗结果.
- 了解性别特异性免疫代谢重编程 (IR) 对于推进精准医学至关重要.
- 未来的研究应该优先考虑基于性别的IR研究,以优化免疫介导疾病治疗和疫苗开发.
更多相关视频
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
7.8K
08:30Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
12.3K
相关概念视频
Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
Cell-mediated Immune Responses
66.7K
Overview
66.7K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
